Q3 FY2026
Filed Nov 10, 2026ICL Q3 2026: sales up 3% to $1,910 million, adjusted EBITDA $402 million, gross margin 32.9%, FY2026 adjusted EBITDA guidance reiterated
Sales, net income attributable to shareholders, adjusted net income and adjusted EBITDA all rose year over year in Q3 2026, and gross margin was 32.9%, up 30 basis points. Operating income, adjusted operating income, operating cash flow and EPS were flat or lower, and the filing reports higher net financing expense and higher inventories. No prior-quarter release or consensus was provided, so the verdict rests on the year-over-year comparisons printed in this filing.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Sales, Q3 2026GAAP | $1.91B | – | 3% |
| Gross profit, Q3 2026GAAP | $628M | – | – |
| Gross margin, Q3 2026GAAP | 32.9% | – | up 30 basis points |
| Cost of sales, Q3 2026GAAP | $1.28B | – | – |
| Selling, transport and marketing expenses, Q3 2026GAAP | $309M | – | – |
| General and administrative expenses, Q3 2026GAAP | $76M | – | – |
| Research and development expenses, Q3 2026GAAP | $13M | – | – |
| Other expenses, Q3 2026GAAP | $9M | – | – |
| Operating income, Q3 2026GAAP | $225M | – | – |
| Adjusted operating income, Q3 2026non-GAAP | $233M | – | – |
| Finance expenses, net, Q3 2026GAAP | $42M | – | – |
| Taxes on income, Q3 2026GAAP | $54M | – | – |
| Net income attributable to shareholders, Q3 2026GAAP | $120M | – | – |
| Adjusted net income attributable to shareholders, Q3 2026non-GAAP | $126M | – | 2% |
| Diluted earnings per share, Q3 2026GAAP | $0.09 | – | – |
| Diluted adjusted earnings per share, Q3 2026non-GAAP | $0.10 | – | – |
| Adjusted EBITDA, Q3 2026non-GAAP | $402M | – | 1% |
| Net cash provided by operating activities, Q3 2026GAAP | $256M | – | – |
| Free cash flow, Q3 2026other | $66M | – | – |
| Purchases of property, plant and equipment and intangible assets, Q3 2026GAAP | $190M | – | – |
| Sales, nine months 2026GAAP | $6.07B | – | – |
| Gross profit, nine months 2026GAAP | $1.92B | – | – |
| Cost of sales, nine months 2026GAAP | $4.15B | – | – |
| Operating income, nine months 2026GAAP | $726M | – | – |
| Adjusted operating income, nine months 2026non-GAAP | $766M | – | – |
| Net income attributable to shareholders, nine months 2026GAAP | $383M | – | – |
| Adjusted net income attributable to shareholders, nine months 2026non-GAAP | $414M | – | – |
| Diluted earnings per share, nine months 2026GAAP | $0.30 | – | – |
| Diluted adjusted earnings per share, nine months 2026non-GAAP | $0.32 | – | – |
| Adjusted EBITDA, nine months 2026non-GAAP | $1.26B | – | – |
| Net cash provided by operating activities, nine months 2026GAAP | $741M | – | – |
| Purchases of property, plant and equipment and intangible assets, nine months 2026GAAP | $522M | – | – |
| Potash CIF price per tonne, Q3 2026other | $370 | – | 4.8% |
| Potash production, Q3 2026other | 1,146 thousand tonnes | – | – |
| Potash total sales including internal sales, Q3 2026other | 1,090 thousand tonnes | – | – |
| Potash total sales including internal sales, nine months 2026other | 3,361 thousand tonnes | – | – |
| Cash, cash equivalents, short-term investments and deposits, as of September 30, 2026other | $637M | – | – |
| Net financial liabilities, as of September 30, 2026other | $2.63B | – | – |
| Total assets, as of September 30, 2026GAAP | $13.28B | – | – |
| Total equity, as of September 30, 2026GAAP | $6.53B | – | – |
| Total shareholders' equity, as of September 30, 2026GAAP | $6.22B | – | – |
| Dividends paid to the Company's shareholders, Q3 2026GAAP | $75M | – | – |
| Dividends paid to the Company's shareholders, nine months 2026GAAP | $204M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Industrial Products, Q3 2026Segment operating income $84 million versus $52 million. Company explanation: quantity was positive, driven by higher flame retardant and clear brine volumes; price was positive, driven by bromine-based flame retardants, bromine-based industrial solutions and specialty minerals; exchange rates and raw materials were negative; operating and other expenses were positive. | $347 million (segment sales; prior year $295 million) | – | – |
| Industrial Products, nine months 2026Segment operating income $270 million versus $168 million. Company explanation: price was the largest positive item; quantity was slightly negative as lower higher-margin bromine-based industrial solution volumes offset higher flame retardant volumes. | $1,110 million (segment sales; prior year $958 million) | – | – |
| Potash, Q3 2026Segment operating income $94 million versus $104 million. Company explanation: quantity was positive on higher potash volumes in India and Brazil; price was positive on a $17 year-over-year increase in potash CIF price per tonne; exchange rates, energy and transportation were negative. | $469 million (segment sales; prior year $453 million) | – | – |
| Potash, nine months 2026Segment operating income $284 million versus $212 million. Company explanation: price was positive on a $41 year-over-year increase in potash CIF price per tonne; quantity was positive on higher volumes in China, Brazil and India; transportation and exchange rates were negative. | $1,440 million (segment sales; prior year $1,241 million) | – | – |
| Phosphate Solutions, Q3 2026Segment operating income $58 million versus $85 million. Company explanation: raw materials were negative due to higher sulphur costs; quantity was negative on lower phosphate fertilizer, industrial salt and MAP volumes; price was positive on higher WPA and fertilizer prices. Phosphate Specialties segment sales were $396 million and Phosphate Commodities were $193 million. | $589 million (segment sales; prior year $605 million) | – | – |
| Phosphate Solutions, nine months 2026Segment operating income $219 million versus $266 million. Company explanation: raw materials were negative due to higher sulphur costs; quantity was negative on lower phosphate fertilizer and industrial salt volumes; price was positive. | $1,990 million (segment sales; prior year $1,815 million) | – | – |
| Growing Solutions, Q3 2026Segment operating income $25 million versus $31 million. Company explanation: quantity was negative on lower specialty agriculture and FertilizerpluS volumes; price was positive on higher prices for specialty agriculture, FertilizerpluS and turf and ornamental products; raw materials were negative on higher commodity fertilizer, sulphur and nitrogen costs. | $538 million (segment sales; prior year $561 million) | – | – |
| Growing Solutions, nine months 2026Segment operating income $87 million versus $94 million. Company explanation: raw materials were negative on higher commodity fertilizer, sulphur and nitrogen costs; quantity was negative on lower specialty agriculture volumes, partly offset by FertilizerpluS; price and exchange rates were positive. | $1,694 million (segment sales; prior year $1,596 million) | – | – |
| Other Activities, Q3 2026Segment operating loss of $2 million versus $6 million in the prior-year quarter, as shown in the operating segment note. Includes Growers and Agmatix and the innovation arm. | $60 million (total sales; prior year $46 million) | – | – |
FY2026 outlook
- NoteConsolidated adjusted EBITDA between $1.5 billion and $1.7 billion (non-GAAP; company states it reiterated this guidance)
- NotePotash sales volumes between 4.5 million and 4.7 million metric tons (company states it continues to expect this range)
Capital returns
- Dividends paid to the Company's shareholders were $75 million in Q3 2026 versus $55 million in Q3 2025, and $204 million in the nine months 2026 versus $162 million in the nine months 2025.
- Dividends paid to non-controlling interests were nil in Q3 2026 versus $22 million in Q3 2025, and $1 million in the nine months 2026 versus $64 million in the nine months 2025.
- No share repurchases are printed in the filing. Treasury shares at cost remained $(260) million at September 30, 2026.
What drove it
- Q3 2026 operating income bridge (company figures, $ millions): Q3 2025 adjusted operating income $241 with price +171, quantity (22), exchange rates (43), raw materials (103), energy (10), transportation (21), operating and other expenses +20, giving adjusted Q3 2026 operating income of $233.
- Price was the largest positive item in the Q3 bridge; the company attributes it primarily to a $17 year-over-year increase in potash CIF price per tonne, plus higher selling prices across phosphate fertilizers, WPA, industrial salts, food specialties additives, specialty agriculture products and bromine-based products.
- Company explanation for the Q3 exchange rate impact: appreciation of the average Israeli shekel and Brazilian real against the US dollar increased operational costs, more than offsetting the positive impact on sales.
- Company explanation for the Q3 raw materials impact: higher cost of sulphur and commodity fertilizers. Transportation was negative on higher marine and inland transportation costs.
- Nine-month operating income bridge (company figures, $ millions): prior-year adjusted operating income $650 with price +536, exchange rates (106), raw materials (278), energy (12), transportation (36), quantity (5), operating and other expenses +17, giving adjusted operating income of $766.
- Financing expenses, net were $42 million in Q3 2026 versus $44 million. The company attributes the decrease primarily to lower expenses from net exchange rate differences and hedging, partly offset by higher net interest expenses. Nine-month financing expenses, net rose to $126 million from $94 million, primarily driven by an increase of $29 million in net interest expenses, per the company.
- Effective tax rate was 30% in Q3 2026 versus 31%, and 30% for the nine months versus 32%, as printed by the company.
- Company explanation for lower Q3 potash volumes in US and Europe being offset: higher potash sales volumes in India and Brazil. Nine-month potash sales rose 240 thousand tonnes, mainly on higher volumes in China, Brazil and India.
- Adjustments to operating income in Q3 2026 were $8 million, all charges related to the security situation in Israel, which the company describes as primarily driven by disruption to shipping routes that resulted in higher marine transportation costs.
Concerns
- Operating income was $225 million in Q3 2026 versus $230 million, and adjusted operating income was $233 million versus $241 million, while sales rose.
- Operating cash flow was $256 million versus $308 million in Q3, and $741 million versus $742 million for the nine months. The company attributes the Q3 decline mainly to higher inventories tied to raw material prices, particularly sulphur.
- Phosphate Solutions segment operating income fell to $58 million from $85 million in Q3, and nine-month segment operating income fell to $219 million from $266 million. The company cites higher sulphur costs and lower volumes.
- Net financial liabilities rose by $366 million to $2,626 million compared with December 31, 2025. Net interest expenses increased, per the company.
- The company states the security situation in Israel has not had a material adverse effect to date, but says its future effects remain uncertain. The filing lists ongoing shipping route disruption and higher shipping costs linked to Houthi attacks.
- Phosphate market: the company reports that key phosphate fertilizer benchmarks declined by an average of 2% during Q3 2026, and that Brazilian phosphate imports fell 24% year over year in Q3.
- Food specialties volumes fell especially in Europe as customers became more selective after price increases, and battery materials volumes in China decreased, per the company.
What to watch
- Whether full-year 2026 consolidated adjusted EBITDA lands within the reiterated $1.5 billion to $1.7 billion range, given nine-month adjusted EBITDA of $1,262 million.
- Whether potash sales volumes reach the 4.5 million to 4.7 million metric ton guidance, given nine-month potash sales of 3,361 thousand tonnes.
- Sulphur cost trajectory: the company cites Middle East FOB spot sulphur down $235 per tonne to $860 per tonne at quarter-end but still historically elevated.
- Working capital and inventory levels, which the company cites as the driver of lower Q3 operating cash flow.
- Effect of the new organizational structure effective January 1, 2027 (Growing Solutions, Nutrition Solutions, Industrial Products and Essential Minerals), and the ELEVATE program, which the CEO says is expected to begin delivering meaningful cost savings. The company is still reviewing the accounting implications for its segment reporting.
- Security situation in Israel and shipping route disruption, which the company says could have uncertain future effects.
- Net interest expense trend following the $800 million Series H issuance and the new €240 million loan.
Balance sheet and cash flow
- Cash, cash equivalents, short-term investments and deposits were $637 million as of September 30, 2026, compared with $496 million as of December 31, 2025.
- Net financial liabilities were $2,626 million as of September 30, 2026, an increase of $366 million compared with December 31, 2025. The company states that the fair value of currency and interest rate swaps economically reduced finance liabilities by approximately $89 million.
- Company explanation for lower Q3 operating cash flow ($256 million versus $308 million): an increase in working capital, primarily higher inventories, mainly as a result of increased raw material prices, particularly sulphur, partly offset by favorable changes in trade receivables and trade payables.
- Net cash used in investing activities was $158 million in Q3 2026 versus $178 million; company explanation: higher net proceeds from deposits, partly offset by higher purchases of property, plant and equipment and lower net proceeds from settlement of derivatives.
- Net cash used in financing activities was $99 million in Q3 2026 versus $353 million; company explanation: higher net proceeds from long-term debt, partly offset by a shift from net receipts to net repayments of short-term debt.
- Series H Debentures: $800 million senior unsecured notes issued June 16, 2026, maturing June 16, 2036, with a 6.036% annual coupon, rated BBB- by S&P Global and Fitch.
- In September 2026 the company repaid its €250 million sustainability-linked loan at maturity and entered into a new €240 million Sustainability-Linked Loan maturing in 2029, bearing variable interest based on EURIBOR plus a spread.
- Revolving Credit Facility: about $284 million was utilized under the $1,650 million facility as of September 30, 2026. In October 2026 an additional bank joined, increasing the total commitment to $1,800 million. The company reports about $1.5 billion of unused credit facilities as of September 30, 2026.
- Securitization: about $199 million was utilized of a committed $350 million, plus an uncommitted $100 million, maturing December 2030.
- Fitch reaffirmed long-term issuer default rating 'BBB-' in April 2026 with a stable outlook. S&P Global Ratings reaffirmed 'BBB-' with a stable outlook in May 2026, and S&P Maalot reaffirmed 'ilAA'. The company states it was in compliance with all financial covenants as of September 30, 2026.
Analysis
ICL reported Q3 2026 sales of $1,910 million, up from $1,853 million, and gross profit of $628 million versus $604 million, with gross margin of 32.9%, which the filing says is up 30 basis points year over year and the highest rate since the fourth quarter of 2024. Adjusted EBITDA rose to $402 million from $398 million and adjusted net income attributable to shareholders rose to $126 million from $124 million. GAAP operating income was $225 million against $230 million, and adjusted operating income was $233 million against $241 million, so the profit growth at the EBITDA and net income level was not matched at the operating line. The company's explanation rests on the Q3 bridge: price was +171 million on a $17 year-over-year increase in potash CIF price, while raw materials (103 million), exchange rates (43 million) and transportation (21 million) absorbed much of it.
By segment, Industrial Products and Potash improved operating income in Q3 while Phosphate Solutions and Growing Solutions declined. Industrial Products rose to $84 million from $52 million and Potash eased to $94 million from $104 million, while Phosphate Solutions fell to $58 million from $85 million and Growing Solutions to $25 million from $31 million. The filing ties the Phosphate Solutions decline to higher sulphur costs and lower volumes, and it reports that phosphate fertilizer benchmarks declined by an average of 2% during the quarter. Potash volumes grew: Q3 total potash sales were 1,090 thousand tonnes versus 1,046 thousand tonnes, and the potash CIF price was $370 per tonne, 4.8% higher year over year.
On the nine-month view, sales rose to $6,068 million from $5,452 million, operating income to $726 million from $596 million, and adjusted EBITDA to $1,262 million from $1,108 million. Diluted EPS was $0.30 versus $0.23 and adjusted diluted EPS was $0.32 versus $0.27. Operating cash flow was essentially flat at $741 million versus $742 million, and capital expenditures were $522 million versus $572 million. Net financing expense rose to $126 million from $94 million, which the company attributes mainly to higher net interest expense.
Cash flow and the balance sheet show the working capital build the company describes. Q3 operating cash flow was $256 million versus $308 million, and free cash flow was $66 million. The company attributes the decline to higher inventories, mainly from raw material prices, particularly sulphur. Net financial liabilities were $2,626 million, up $366 million from December 31, 2025. Liquidity was $637 million of cash, deposits and short-term investments, with about $1.5 billion of unused credit facilities, and a $1,650 million revolving facility that was increased to $1,800 million in October 2026. Dividends paid to shareholders rose to $75 million in Q3 from $55 million.
Full-year guidance was reiterated: consolidated adjusted EBITDA between $1.5 billion and $1.7 billion and potash sales volumes between 4.5 million and 4.7 million metric tons. Management's outlook emphasizes the new segment structure effective January 1, 2027 and the ELEVATE cost program, which the CEO says is expected to begin delivering meaningful cost savings.
Management, verbatim
ICL delivered another quarter of growth in sales, net income and adjusted EBITDA, as we successfully navigated record high raw material prices, elevated freight and logistics costs, and the impact of exchange rate fluctuations.
Elad Aharonson, President and CEO
Looking ahead, we expect to enter 2027 from a position of strength.
Elad Aharonson, President and CEO
Not in the filing
stated, not guessed- Prior-quarter (Q2 2026) income statement and segment figures are not printed in this filing, so prior_quarter and qoq_change fields are null.
- Prior-year gross margin percentage for Q3 2025 is not printed (only the 30 basis point change is stated).
- Year-over-year dollar change for gross profit, operating income and several expense lines is not printed and is left null.
- Free cash flow for Q3 2025 is not printed; the Q3 2026 free cash flow of $66 million is shown with no comparison.
- Year-over-year percentage change for segment sales is not printed for each segment.
- Consensus estimates, analyst expectations and share price reaction are not provided in the documents.
- Revenue guidance, gross margin guidance, operating expense guidance and tax rate guidance for FY2026 are not provided.
- Share repurchase activity is not printed in the filing.
- The fair value and carrying amount table in Note 5 is incomplete in the supplied text, so no fair value figures are reported.
- Pre-2026 segment comparatives under the new organizational structure effective January 1, 2027 are not provided.
- The previous outlook covered the full year 2026 only, and this release reports Q3 2026, so there is no comparable guidance for this quarter.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.